Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
432.71
-7.24 (-1.65%)
Oct 26, 2026, 11:43 AM EDT - Market open
Elevance Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 201,832 | 199,126 | 176,810 | 171,340 | 156,599 | 138,643 |
Revenue Growth | 3.60% | 12.62% | 3.19% | 9.41% | 12.95% | 13.76% |
Operating Income Operating Income Growth | 8,027 | 8,297 | 9,863 | 9,889 | 8,462 | 9,027 |
Net Income Net Income Growth | 5,139 | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Earnings Per Share EPS Growth | 23.44 | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 |
EPS Growth | -3.90% | -1.83% | 1.82% | 3.87% | -2.69% | 38.77% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Health Benefits Health Benefits Growth | 170,402 | 167,094 | 150,275 | 148,571 | 138,484 | 121,728 |
CarelonRx CarelonRx Growth | 45,093 | 43,400 | 35,961 | - | - | - |
Carelon Services Carelon Services Growth | 30,063 | 28,316 | 17,961 | - | - | - |
Corporate & Other Corporate & Other Growth | -67 | 463 | 309 | 479 | 399 | 95 |
Revenue (Total) Revenue (Total) Growth | 199,071 | 197,584 | 175,204 | 170,209 | 155,660 | 136,943 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 10,348 | 9,491 | 8,288 | 6,526 | 7,387 | 4,880 |
Total Debt Total Debt Growth | 30,757 | 32,750 | 32,193 | 25,969 | 25,046 | 24,028 |
Net Cash (Debt) Net Cash Growth | -20,409 | -23,259 | -23,905 | -19,443 | -17,659 | -19,148 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -93.04 | -103.56 | -102.64 | -81.90 | -72.73 | -77.59 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 7,596 | 4,290 | 5,808 | 8,061 | 8,399 | 8,364 |
Capital Expenditures CapEx Growth | -1,082 | -1,116 | -1,256 | -1,296 | -1,152 | -1,087 |
Free Cash Flow Free Cash Flow Growth | 6,514 | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 |
Free Cash Flow Growth | 72.92% | -30.27% | -32.71% | -6.65% | -0.41% | -24.72% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Margin | 3.98% | 4.17% | 5.58% | 5.77% | 5.40% | 6.51% |
Pretax Margin | 3.10% | 3.37% | 4.47% | 4.50% | 4.85% | 5.77% |
Profit Margin | 2.55% | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% |
FCF Margin | 3.23% | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 6.880 | 6.840 | 6.520 | 5.920 | 5.120 | 4.520 |
Dividend Per Share Growth | 0.58% | 4.91% | 10.13% | 15.63% | 13.27% | 18.95% |
Dividend Yield | 1.59% | 1.94% | 1.73% | 1.24% | 0.99% | 0.97% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.46 | 13.76 | 14.31 | 18.51 | 20.79 | 18.27 |
Forward PE | 15.09 | 13.09 | 11.25 | 13.17 | 16.14 | 16.70 |
P/FCF Ratio | 14.61 | 24.55 | 18.80 | 16.38 | 16.91 | 15.46 |
PS Ratio | 0.47 | 0.39 | 0.48 | 0.65 | 0.78 | 0.81 |